{"id":27681,"date":"2022-08-01T09:00:00","date_gmt":"2022-08-01T09:00:00","guid":{"rendered":"https:\/\/d36deud6t4mnhi.cloudfront.net\/press-releases\/ipsen-et-marengo-therapeutics-annoncent-la-conclusion-dun-partenariat-strategique-afin-de-developper-deux-traitements-candidats-de-precision-en-immuno-oncologie-en-phase-clinique-a-partir-de\/"},"modified":"2024-07-22T12:27:59","modified_gmt":"2024-07-22T10:27:59","slug":"ipsen-et-marengo-therapeutics-annoncent-la-conclusion-dun-partenariat-strategique-afin-de-developper-deux-traitements-candidats-de-precision-en-immuno-oncologie-en-phase-clinique-a-partir-de","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-et-marengo-therapeutics-annoncent-la-conclusion-dun-partenariat-strategique-afin-de-developper-deux-traitements-candidats-de-precision-en-immuno-oncologie-en-phase-clinique-a-partir-de\/","title":{"rendered":"Ipsen et Marengo Therapeutics annoncent la conclusion d\u2019un partenariat strat\u00e9gique afin de d\u00e9velopper deux traitements candidats de pr\u00e9cision en immuno-oncologie en phase clinique \u00e0 partir de la plateforme STAR de Marengo"},"content":{"rendered":"\n